PALTAC CORPORATION
8283・Prime Market・Wholesale Trade
Business
PALTAC Corporation is a wholesale specialist in cosmetics, daily necessities, over-the-counter pharmaceuticals, and related products, operating as a subsidiary of Medipal Holdings. The company purchases products from manufacturers and sells them to nationwide retailers such as drugstores, convenience stores, and supermarkets, functioning as an intermediate distributor. It provides logistics, inventory management, information transmission, and financial functions as a one-stop service, contributing to the optimization and efficiency of the entire supply chain. In FY2026 (ending March 2026), net sales reached ¥1,237,846 million, with drugstores accounting for approximately 65% of sales. Founded in 1898, the company operates RDCs (large-scale distribution centers) and FDCs (frontline distribution centers) nationwide.
Business Model
A wholesale model that purchases cosmetics, daily necessities, pharmaceuticals, and other products from manufacturers and sells them to mass merchandisers, retailers, and wholesalers nationwide. Although the gross profit margin is thin at 7.46% (FY2026, ending March 2026), the company acquires and retains business from both manufacturers and retailers by providing added value through highly efficient logistics via its nationwide RDC and FDC network, as well as sales support functions that leverage purchasing data.
Company Strengths
Since the opening of RDC Kinki in 1999, the company has progressively established RDCs and FDCs nationwide, from Hokkaido to Okinawa. In FY2026 (ending March 2026), total capital expenditure amounted to ¥2,661 million, including the new establishment of RDC Shiga (¥616 million) and FDC Kanagawa (¥390 million). A next-generation logistics model (tentatively named RDC Kaizuka) is also under planning, giving the company a logistics infrastructure that is difficult for competitors to replicate in the short term.
In FY2026 (ending March 2026), sales to drugstores amounted to ¥803,973 million (65.0% of total sales). Sales to the largest customer, Matsumotokiyoshi Cocokara & Company, reached ¥133,361 million (10.8% of total sales). The company continues to pursue new account acquisitions, forming a stable sales base through sales to major retail formats.
The company leverages purchasing data to accurately capture changes in consumer behavior, such as growing health consciousness and outing-related demand, and develops sales activities accordingly. It has expanded its lineup of new high-value-added products, primarily in cosmetics, resulting in FY2026 (ending March 2026) cosmetics sales of ¥294,682 million (up 4.6% year on year) and daily necessities sales of ¥556,457 million (up 5.9% year on year), maintaining growth in key categories.
ENVALITH's Perspective
Performance Trend
Revenue increased for five consecutive periods (CAGR of approximately 4.3%), from ¥1,045,735 million in FY2022 (ended March 2022) to ¥1,237,846 million in FY2026 (ending March 2026). As an external factor, rising selling prices amid inflation contributed to the revenue increase. Meanwhile, operating profit peaked at ¥28,008 million in FY2025 (ended March 2025) before declining to ¥26,430 million in FY2026. The rise in personnel expenses and logistics costs (delivery costs of ¥13,890 million, up +10.6% year on year) outpaced the increase in gross profit, causing the operating profit margin to decline from 2.36% to 2.14%. Net income also fell to ¥22,031 million (down △3.6% year on year), declining for the second consecutive period. Operating cash flow improved year on year to ¥24,929 million, and cash balance increased to ¥83,282 million.
Growth Strategy
Under the medium-term management plan 'PALTAC VISION 2027,' the company is promoting structural reform and the development of a next-generation logistics model
Sales are being expanded through the sophistication of sales activities utilizing purchasing data and the expansion of value-added products centered on cosmetics. In FY2026 (ending March 2026), Daily Necessities Wholesale (+5.9%), Cosmetics Wholesale (+4.6%), and Health & Hygiene Products Wholesale (+4.0%) drove revenue growth, but rising costs are pressuring profits, and improving profitability remains an ongoing challenge.
The company is developing a next-generation new logistics model that further evolves the SPAID model, and is constructing a new logistics center in Kaizuka City, Osaka Prefecture. The large-scale facility, with a site area of 23,690 tsubo and a total floor area of approximately 14,980 tsubo, is planned with total investment of ¥34.9 billion funded entirely from internal resources. The company aims to achieve overwhelmingly higher productivity compared to conventional facilities.
The company is promoting the construction of a borderless supply chain network that connects distribution processes with digital information, eliminating inefficiencies, waste, and unevenness in distribution. This has been monetized as information provision fee revenue (¥1,912 million in FY2026 (ending March 2026)), strengthening the provision of added value to both manufacturers and retailers.
Under the medium-term management plan, the company has continued to increase dividends with a target dividend payout ratio of 35% or higher. The annual dividend for FY2026 (ending March 2026) was ¥120 per share (up ¥15 year on year), with a dividend payout ratio of 33.4%. Share buybacks have also been conducted (881,800 shares acquired in August 2025, with 1,000,000 shares retired). However, due to the planned delisting, the company has already resolved to pay no dividend in FY2027 (ending March 2027).
Last updated: July 19, 2026